A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...

Make sure you scroll down on the MLB.tv homepage to have the ability to select the free trial: The ability to select MLB.tv free trial is further down the page As a baseball fan, having access to ...

Rnai Therapeutics Market To Hit $8.8B By 2033, Driven By Rare & Cardiovascular Diseases & Sirna And Delivery Innovations. therapeutics represent one of the most exciting frontiers in precision ...

A group of RNA veterans is launching a new start-up aimed at getting RNA-interfering (RNAi) molecules into the brain to ...

CRISPR Therapeutics has developed SyNTase editing, a proprietary, next-generation, site-specific gene correction platform.

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the Unstoppable Stocks to Buy and Hold for the Next 5 Years. On September 23, analyst Mitchell Kapoor from H.C. Wainwright reiterated a “Buy” rating on ...

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...